These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 17080429)

  • 1. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders.
    Rodriguez MC; MacDonald JR; Mahoney DJ; Parise G; Beal MF; Tarnopolsky MA
    Muscle Nerve; 2007 Feb; 35(2):235-42. PubMed ID: 17080429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies.
    Tarnopolsky MA
    Adv Drug Deliv Rev; 2008; 60(13-14):1561-7. PubMed ID: 18647623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of coenzyme Q10 in mitochondrial disorders.
    Glover EI; Martin J; Maher A; Thornhill RE; Moran GR; Tarnopolsky MA
    Muscle Nerve; 2010 Nov; 42(5):739-48. PubMed ID: 20886510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Only transient increase of serum CoQ subset 10 during long-term CoQ10 therapy in mitochondrial ophthalmoplegia.
    Hanisch F; Zierz S
    Eur J Med Res; 2003 Nov; 8(11):485-91. PubMed ID: 14644702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction.
    Orsucci D; Filosto M; Siciliano G; Mancuso M
    Nutr Rev; 2009 Aug; 67(8):427-38. PubMed ID: 19674340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders.
    Marriage BJ; Clandinin MT; Macdonald IM; Glerum DM
    Mol Genet Metab; 2004 Apr; 81(4):263-72. PubMed ID: 15059613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
    Haas RH
    Mitochondrion; 2007 Jun; 7 Suppl():S136-45. PubMed ID: 17485245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
    Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
    Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioenergetic approaches for neuroprotection in Parkinson's disease.
    Beal MF
    Ann Neurol; 2003; 53 Suppl 3():S39-47; discussion S47-8. PubMed ID: 12666097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.
    Shah SA; Sander S; Cios D; Lipeika J; Kluger J; White CM
    Ann Pharmacother; 2007 Mar; 41(3):420-5. PubMed ID: 17341532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q 10 improves lactic acidosis, strokelike episodes, and epilepsy in a patient with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes).
    Berbel-Garcia A; Barbera-Farre JR; Etessam JP; Salio AM; Cabello A; Gutierrez-Rivas E; Campos Y
    Clin Neuropharmacol; 2004; 27(4):187-91. PubMed ID: 15319706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological mitochondrial cytopathies.
    Mehndiratta MM; Agarwal P; Tatke M; Krishnamurthy M
    Neurol India; 2002 Jun; 50(2):162-7. PubMed ID: 12134180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 in phenylketonuria and mevalonic aciduria.
    Hargreaves IP
    Mitochondrion; 2007 Jun; 7 Suppl():S175-80. PubMed ID: 17442628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study.
    Kornblum C; Schröder R; Müller K; Vorgerd M; Eggers J; Bogdanow M; Papassotiropoulos A; Fabian K; Klockgether T; Zange J
    Eur J Neurol; 2005 Apr; 12(4):300-9. PubMed ID: 15804248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effect of coenzyme Q10 and lipoic acid on obstructive bladder dysfunction in the rabbit.
    Juan YS; Levin RM; Chuang SM; Hydery T; Li S; Kogan B; Schuler C; Huang CH; Mannikarottu A
    J Urol; 2008 Nov; 180(5):2234-40. PubMed ID: 18804800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies.
    Femiano F
    Minerva Stomatol; 2002 Sep; 51(9):405-9. PubMed ID: 12473978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
    Magis D; Ambrosini A; Sándor P; Jacquy J; Laloux P; Schoenen J
    Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction and chronic disease: treatment with natural supplements.
    Nicolson GL
    Altern Ther Health Med; 2014; 20 Suppl 1():18-25. PubMed ID: 24473982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of creatine in neuromuscular and neurometabolic disorders.
    Tarnopolsky MA
    Subcell Biochem; 2007; 46():183-204. PubMed ID: 18652078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study.
    Chen RS; Huang CC; Chu NS
    Eur Neurol; 1997; 37(4):212-8. PubMed ID: 9208260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.